Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Tranylcypromine Treatment for Refractory Depression
NCT00296686Phase 4Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Sep 2001
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranylcypromine in major depressive disorder (MDD), sponsored by New York State Psychiatric Institute. Started Sep 2001; status: terminated.
02
Drugs
tranylcypromine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00296686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296686.